These observations notwithstanding, we observed a significant increase in tumor-infiltrating CD8+ T cells in tumors treated with PA-mL7N (at 8 mg/kg) but not in tumors treated with the anti-PD-1 antibody (Figure 6F). This evidence concerns the gene CD8A and neoplasm.